Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 524 of 6351
-
Lab-Grown cells could seal bile leaks without more surgery
Disease control Not yet recruitingBackground: Bile leakage remains a major complication after hepatobiliary surgery and liver transplantation. While most cases are managed through standard radiologic or endoscopic interventions, a subset of patients fails to respond and may face recurrent interventions or even re…
Phase 2 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New hope for deadliest breast cancer complication: drug combo trial launches
Disease control Recruiting nowLeptomeningeal metastases (LM) is a lethal complication of malignant tumors, characterized by tumor cell invasion and proliferation within the subarachnoid space. LM from HER2-negative breast cancer remains challenging to treat, with a median overall survival of only 3-6 months d…
Phase 1/2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Can dry plasma save lives in the field? new trial aims to find out
Disease control Not yet recruitingThe overall goal of this clinical trial is to study how prehospital transfused dry plasma affect outcomes in terms of mortality as well as complications and coagulation status of patients in or about to develop bleeding shock. Researchers will compare dry plasma to standard care…
Phase 4 • Sponsor: Vastra Gotaland Region • Aim: Disease control
Last updated Jun 26, 2026 18:17 UTC
-
New spray chemotherapy trial targets Hard-to-Treat ovarian cancer
Disease control Not yet recruitingThe purpose of this study is to evaluate the tolerance, safety, efficacy, and pharmacokinetics of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with paclitaxel in patients with platinum-resistant recurrent ovarian cancer and peritoneal carcinomatosis.
Phase 1/2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Massive french study to test if RSV antibody shot stops childhood wheezing
Prevention Not yet recruitingEarly respiratory syncytial virus (RSV) bronchiolitis is a well-known contributing factor of mid- and long-term respiratory sequelae in children such as recurrent lower tract respiratory infections (LRTIs), preschool wheezing (PW) or decreased lung function at older ages. Nirsev…
Sponsor: Hospices Civils de Lyon • Aim: Prevention
Last updated Jun 27, 2026 08:09 UTC
-
Could a pill replace IV drips for leukemia patients?
Disease control Not yet recruitingLATITUDE: A Phase 3, Randomized, Open-Label, 3-Cohort, 2-Period, 2- Sequence, Crossover Trial to Evaluate the Pharmacokinetics, Safety, and Efficacy of Oral Arsenic Trioxide Versus Intravenous Arsenic Trioxide for Consolidation Therapy in Participants With Newly Diagnosed, Non-Hi…
Phase 3 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New scanner could slash repeat breast surgeries
Diagnosis Not yet recruitingAccurate intraoperative margin assessment in breast cancer surgery remains challenging. Current reliance on frozen section pathology is limited by prolonged processing time, sampling constraints, and resource intensity, contributing to variable outcomes. The EndoSCell Scanner is…
Sponsor: West China Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New cocktail aims to outsmart Drug-Resistant liver cancer
Disease control Not yet recruitingBackground: Hepatocellular carcinoma (HCC) stands as a formidable global health challenge. It ranks as the sixth most common malignant solid tumor worldwide and the third leading cause of cancer-related mortality. The disease is characterized by its insidious onset, rapid progres…
Phase 2 • Sponsor: First Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New hope for severe stroke: clot removal procedure tested
Disease control Not yet recruitingThis study assesses the efficacy and safety of endovascular therapy in patients with acute basilar artery occlusion with large core infarction within a multicenter, prospective, open-label, blinded endpoint, randomized controlled trial
Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New male contraceptive device aims to be reversible
Disease control Recruiting nowProspective, multicenter, single-arm, open label, interventional clinical trial investigating the safety and effectiveness of the Plan A Male Contraceptive System to occlude the vas deferens to block the passage of sperm and then be reversed to subsequently allow the passage of s…
Phase 2 • Sponsor: Next Life Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Armored cells take on tough lymphoma in early trial
Disease control Recruiting nowThe purpose of this study is to investigate the safety and tolerability of anti-PD1 armored CD19 CAR-T Cells in adult subjects with relapsed or refractory diffuse large B-cell lymphoma.
Phase 1 • Sponsor: Jiangsu Topcel-KH Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug duo takes on stubborn Epstein-Barr virus
Disease control Recruiting nowThis study is a multicenter, prospective, single-arm clinical investigation, with patients with CAEBVD as the main research subjects, to evaluate the effectiveness of the combined treatment regimen of golidocitinib and selinexor.
Phase 2/3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo therapy shows promise for tough esophageal cancer
Disease control Recruiting nowThis is a prospective, randomized, phase II clinical study in patients with unresectable stage III-IVA esophageal squamous cell carcinoma (ESCC). Eligible patients will be randomly assigned in a 1:1 ratio to two treatment groups. The experimental group will receive 3 cycles of in…
Phase 2 • Sponsor: Second Affiliated Hospital of Zunyi Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Growing new skin in minutes: a breakthrough for chronic wounds?
Disease control Recruiting nowThis multicenter real-world study evaluates the efficacy and safety of a novel technique for rapid intraoperative construction of tissue-engineered skin using autologous epidermal stem cells (EpiSCs) for repairing difficult-to-heal wounds. Eligible patients are randomized to rece…
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
AI-Powered ECG could spot silent heart failure in minutes
Diagnosis Recruiting nowThis prospective observational cohort study aims to evaluate the clinical performance of a deep learning-based electrocardiography (ECG) algorithm (DeepECG LVSD) for detecting left ventricular systolic dysfunction (LVSD), defined as left ventricular ejection fraction (LVEF) ≤40%,…
Sponsor: Ajou University School of Medicine • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
New combo aims to stall lung cancer when targeted pills start to fail
Disease control OngoingThis is a prospective, single-center, Phase II clinical study designed to explore the efficacy and safety of ivonescimab plus third-generation EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer who developed slow progression or potential progression after …
Phase 2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
AI reads skin biopsies to spot hidden lymphomas
Diagnosis OngoingCutaneous lymphoproliferative diseases (CLPDs) are a group of skin disorders that range from benign conditions, such as pseudolymphomas, to malignant forms like cutaneous T-cell and B-cell lymphomas. Mycosis fungoides is the most common malignant type, but diagnosis is often diff…
Sponsor: Cairo University • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
AI reads eye scans to spot thyroid disease activity and severity
Diagnosis Recruiting nowThe goal of this observational study is to prospectively validate the efficacy of an AI multimodal model constructed based on multi - sequence orbital MRI in the diagnosis, activity and severity assessment, and prognosis prediction of thyroid - associated ophthalmopathy (TAO) in …
Sponsor: Shanghai Changzheng Hospital • Aim: Diagnosis
Last updated Jul 23, 2026 00:00 UTC
-
Could a common asthma drug shorten bronchiolitis hospital stays?
Disease control Recruiting nowThis study aims to evaluate the role of Montelukast in management of acute Bronchiolitis in indoor patient and how this drug shortens the duration of admission and improves symptoms
Phase 2 • Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Sand and sea: a promising recipe to keep older adults strong and steady?
Prevention CompletedThis study aims to investigate the effects of an 8-week combined land and aquatic exercise program (conducted 3 days per week) on physical performance, recreational swimming behaviors, and water-related risk perceptions in older adults. Physical performance is evaluated using han…
Sponsor: Eskisehir Technical University • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC